BlackRock Science and Technology Term Trust (NASDAQ:BSTZ – Get Free Report) Portfolio Manager Tony Kim acquired 41,825 shares of the business’s stock in a transaction dated Thursday, February 5th. The stock was acquired at an average cost of $22.00 per share, for a total transaction of $920,150.00. Following the transaction, the portfolio manager owned 251,554 shares of the company’s stock, valued at $5,534,188. This represents a 19.94% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
BlackRock Science and Technology Term Trust Trading Up 2.3%
Shares of BlackRock Science and Technology Term Trust stock traded up $0.53 during trading hours on Monday, reaching $23.09. 135,083 shares of the company’s stock were exchanged, compared to its average volume of 306,194. The company has a 50 day moving average of $22.67 and a two-hundred day moving average of $22.19. BlackRock Science and Technology Term Trust has a fifty-two week low of $15.22 and a fifty-two week high of $23.47.
BlackRock Science and Technology Term Trust Dividend Announcement
The business also recently disclosed a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Friday, March 13th will be paid a dividend of $0.1625 per share. The ex-dividend date is Friday, March 13th. This represents a c) dividend on an annualized basis and a dividend yield of 8.4%.
Institutional Trading of BlackRock Science and Technology Term Trust
About BlackRock Science and Technology Term Trust
BlackRock Science and Technology Term Trust (NASDAQ: BSTZ) is a closed-end management investment company that provides targeted exposure to companies engaged in the science and technology sectors. Listed on the NASDAQ stock exchange, the trust seeks to deliver total return composed of capital appreciation and monthly distributions over a defined term. It operates as a term trust, with an anticipated liquidation date in August 2028, at which point shareholders will receive proceeds based on the trust’s net asset value.
The trust’s investment strategy is centered on equity and equity-related securities of companies involved in advancing scientific research, technological innovation and related applications.
Featured Articles
- Five stocks we like better than BlackRock Science and Technology Term Trust
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for BlackRock Science and Technology Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Science and Technology Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
